Amylyx Pharmaceuticals, Inc. (AMLX) operating margin

Operating margin · fiscal 2024
-292.6%

Amylyx Pharmaceuticals, Inc. (AMLX) had an operating margin of -292.6% in fiscal 2024 (the year ended December 31, 2024). That is 302.8 percentage points lower than the 10.2% of fiscal 2023. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2024
-292.6%
Change on fiscal 2023
−302.8 pts
Highest on record
10.2%fiscal 2023
Lowest on record
-29013.3%fiscal 2021
Fiscal years on record
42021–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Amylyx Pharmaceuticals, Inc. operating margin, in more detail

Across the 4 fiscal years on record (2021–2024), the highest was 10.2% in fiscal 2023 and the lowest -29013.3% in fiscal 2021. The fiscal 2024 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is -905.7%.

Gross margin was -42.6% in fiscal 2024. Net margin was -345.4% in fiscal 2024.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Amylyx Pharmaceuticals, Inc. operating margin, year by year

Amylyx Pharmaceuticals, Inc. (AMLX) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2024-292.6% 302.8 pts down-42.6%-345.4%
202310.2% 915.9 pts up93.3%12.9%
2022-905.7% 28107.6 pts up86.5%-892.4%
2021-29013.3%——-30853.0%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on AMLX

Amylyx Pharmaceuticals, Inc., figure by figure

Amylyx Pharmaceuticals, Inc. (AMLX) overview: price, valuation and scorecard

Amylyx Pharmaceuticals, Inc. operating margin: questions and answers

What is Amylyx Pharmaceuticals, Inc.'s operating margin?

Amylyx Pharmaceuticals, Inc. (AMLX) had an operating margin of -292.6% in fiscal 2024 (the year ended December 31, 2024). That is 302.8 percentage points lower than the 10.2% of fiscal 2023.

Is Amylyx Pharmaceuticals, Inc.'s operating margin high or low compared with its own history?

The fiscal 2024 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is -905.7%.

What are the highest and lowest operating margin figures on record for Amylyx Pharmaceuticals, Inc.?

Across the 4 fiscal years on record (2021–2024), the highest was 10.2% in fiscal 2023 and the lowest -29013.3% in fiscal 2021.

What are Amylyx Pharmaceuticals, Inc.'s gross and net margins?

Gross margin was -42.6% in fiscal 2024. Net margin was -345.4% in fiscal 2024.

How is Amylyx Pharmaceuticals, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Amylyx Pharmaceuticals, Inc. it is on record here for 4 fiscal years, 2021 to 2024.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amylyx Pharmaceuticals, Inc. (AMLX) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/AMLX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.